Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gilles Crehange

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
La Revue Du Praticien|April 2, 2011
[Main indications of radiation oncology]Philippe Maingon, Gilles Crehange
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2019
Definitive Chemoradiotherapy for Esophageal Squamous Cell Cancer: A Matter of StandardAntoine Adenis, Gilles Crehange, Thierry Conroy
IEEE Transactions on Medical Imaging|February 19, 2021
Learning With Context Feedback Loop for Robust Medical Image SegmentationKibrom Berihu Girum, Gilles Crehange, Alain Lalande
Breast (Edinburgh, Scotland)|February 15, 2026
Toward genomic personalization of breast cancer radiotherapy: foundations, challenges, and a roadmap for clinical integrationPierre Loap, Irene Buvat, Gilles Crehange, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|August 29, 2025
Genomic analysis of radiosensitivity in breast cancer : Identifying pathological determinants and assessing genomic-adjusted radiation dose (GARD) for personalized dose escalationPierre Loap, Irène Buvat, Alain Fourquet, et al.
Therapeutic Advances in Urology|October 22, 2025
Treatment of aggressive prostate cancer with triptorelin in real life in France: the TALISMAN studyThierry Lebret, Gilles Crehange, Nathalie Pello-Leprince-Ringuet, et al.
European Urology|December 6, 2020
Re: Adjuvant Radiotherapy Versus Early Salvage Radiotherapy plus Short-term Androgen Deprivation Therapy in Men with Localised Prostate Cancer After Radical Prostatectomy (GETUG-AFU 17): A Randomised, Phase 3 TrialLara Rodríguez-Sánchez, Gilles Crehange, Mostefa Bennamoun, et al.
Technology in Cancer Research & Treatment|October 23, 2018
Hypofractionated Stereotactic Radiotherapy as a Salvage Therapy for Recurrent High-Grade Gliomas: Single-Center ExperienceThomas Reynaud, Aurélie Bertaut, Walid Farah, et al.
Practical Radiation Oncology|July 16, 2022
Safety and Efficacy of Stereotactic Ablative Radiation Therapy for Renal Cell Cancer: 24-Month Results of the RSR1 Phase 1 Dose Escalation StudyAriane Lapierre, Lionel Badet, Olivier Rouviere, et al.
Technology in Cancer Research & Treatment|June 3, 2020
Patterns of Failure in Patients With Head and Neck Squamous Cell Carcinomas of Unknown Primary Treated With ChemoradiotherapyFatma Dhouib, Aurélie Bertaut, Philippe Maingon, et al.
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
La Revue Du Praticien|April 2, 2011
[Main indications of radiation oncology]Philippe Maingon, Gilles Crehange
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2019
Definitive Chemoradiotherapy for Esophageal Squamous Cell Cancer: A Matter of StandardAntoine Adenis, Gilles Crehange, Thierry Conroy
IEEE Transactions on Medical Imaging|February 19, 2021
Learning With Context Feedback Loop for Robust Medical Image SegmentationKibrom Berihu Girum, Gilles Crehange, Alain Lalande
Breast (Edinburgh, Scotland)|February 15, 2026
Toward genomic personalization of breast cancer radiotherapy: foundations, challenges, and a roadmap for clinical integrationPierre Loap, Irene Buvat, Gilles Crehange, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|August 29, 2025
Genomic analysis of radiosensitivity in breast cancer : Identifying pathological determinants and assessing genomic-adjusted radiation dose (GARD) for personalized dose escalationPierre Loap, Irène Buvat, Alain Fourquet, et al.
Therapeutic Advances in Urology|October 22, 2025
Treatment of aggressive prostate cancer with triptorelin in real life in France: the TALISMAN studyThierry Lebret, Gilles Crehange, Nathalie Pello-Leprince-Ringuet, et al.
European Urology|December 6, 2020
Re: Adjuvant Radiotherapy Versus Early Salvage Radiotherapy plus Short-term Androgen Deprivation Therapy in Men with Localised Prostate Cancer After Radical Prostatectomy (GETUG-AFU 17): A Randomised, Phase 3 TrialLara Rodríguez-Sánchez, Gilles Crehange, Mostefa Bennamoun, et al.
Technology in Cancer Research & Treatment|October 23, 2018
Hypofractionated Stereotactic Radiotherapy as a Salvage Therapy for Recurrent High-Grade Gliomas: Single-Center ExperienceThomas Reynaud, Aurélie Bertaut, Walid Farah, et al.
Practical Radiation Oncology|July 16, 2022
Safety and Efficacy of Stereotactic Ablative Radiation Therapy for Renal Cell Cancer: 24-Month Results of the RSR1 Phase 1 Dose Escalation StudyAriane Lapierre, Lionel Badet, Olivier Rouviere, et al.
Technology in Cancer Research & Treatment|June 3, 2020
Patterns of Failure in Patients With Head and Neck Squamous Cell Carcinomas of Unknown Primary Treated With ChemoradiotherapyFatma Dhouib, Aurélie Bertaut, Philippe Maingon, et al.
Pageof 5